TY  - JOUR 
T1  - The efficacy and sustainability of a reduced risankizumab dose after achievement of low disease activity of psoriasis: a 24-week study<sup/>
JO  - Anais Brasileiros de Dermatologia
A1  - Ulutaş, Gizem Pehlivan
A1  - Akbulut, Tuğba Özkök
A1  - Ekinci, Algün Polat
SN  - 0365-0596
UL  - 10.1016/j.abd.2026.501335
VL  - 101 
Y1  - 2026
PB  - Brasil 
ER  -